Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;27(7):2190-2204.
doi: 10.1007/s10461-022-03951-8. Epub 2023 Mar 7.

Women Want Choices: Opinions from the Share.Learn.Shape Global Internet Survey About Multipurpose Prevention Technology (MPT) Products in Development

B A Friedland  1 , M Plagianos  2 , C Savel  3 , V Kallianes  2 , C Martinez  4 , L Begg  2 , K M Guthrie  5   6 , D Venkatasetty  2 , J Pickett  7 , L B Haddad  2
Affiliations

Women Want Choices: Opinions from the Share.Learn.Shape Global Internet Survey About Multipurpose Prevention Technology (MPT) Products in Development

B A Friedland et al. AIDS Behav. 2023 Jul.

Abstract
in English, Spanish

Women need multipurpose prevention technologies (MPTs) to simultaneously prevent sexually transmitted infections (STIs), including HIV, with or without contraception. User feedback early in product development is critical for maximizing uptake and continuation. Our global online survey (April 2017-December 2018) explored women's opinions about MPT formulations in development (e.g., fast-dissolving vaginal inserts, vaginal films, intravaginal rings, injectables, implants), preferences for long-acting or "on-demand" methods, and interest in a contraceptive MPT versus products for HIV/STI prevention alone. Of the 630 women in our final analysis (mean 30 years old; range 18-49), 68% were monogamous, 79% completed secondary education, 58% had ≥ 1 child, 56% were from sub-Saharan Africa and 82% preferred a cMPT versus HIV/STI prevention alone. There were no clear preferences for any specific product or product type (long-acting, on-demand, daily). No single product will appeal everyone, however, adding contraception is likely to increase uptake of HIV/STI prevention methods for most women.

Las mujeres necesitan tecnologías de prevención multipropósito (TPM) para prevenir simultáneamente las infecciones de transmisión sexual (ITS), incluido el VIH, con o sin anticoncepción. Las opiniones de los usuarios cuando un producto comienza a desarrollarse son fundamentales para maximizar la adopción y continuación de dicho producto. Nuestra encuesta global realizada en internet (abril de 2017–diciembre de 2018) exploró las opiniones de las mujeres sobre diferentes fórmulas o dispositivos de TPM que se están desarrollando (ej., insertos vaginales de disolución rápida, láminas vaginales, anillos intravaginales, inyectables, implantes). En esta encuesta se indagó acerca de las preferencias en términos de período de acción (prolongado o breve) y propósito del uso (anticonceptivo, productos para la prevención del VIH/ITS, o ambos). De las 630 mujeres (media de 30 años; rango 18–49) en el análisis final, el 68% eran monógamas, el 79% completaron la educación secundaria, el 58% tenían ≥ 1 hijo, el 56% eran del África subsahariana y el 82% preferían una TPM con componente anticonceptivo en vez de un producto para la prevención de VIH/ITS exclusivamente. No hubo preferencias claras por ningún producto o tipo de producto específico (de acción prolongada, de acción breve, de uso diario). Ningún producto por sí solo logró abarcar todas las preferencias; sin embargo, es probable que la inclusión de métodos anticonceptivos en una TPM aumente el uso de métodos de prevención del VIH/ITS en la mayoría de las mujeres.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Interest in MPT products, by low- and middle-income (LMIC) vs high-income countries (HIC), product interest sub-group (PIS) (n = 630). *Indicates significant (chi-square p < 0.05) difference between LMIC and HIC responses: pill before sex chi-square = 5.32 p = 0.021; implant chi-square = 4.49 p = 0.034; IVR chi-square = 5.49 p = 0.019; injection chi-square = 34.2 p < 0.0001; any long acting chi-square = 19.4 p < 0.0001; only on demand chi-square = 4.15 p = 0.042. Long acting includes implant, IVR, injection; On demand includes vaginal gel before sex, FDI before sex, pill before sex, vaginal film before sex, vaginal gel after sex
See this image and copyright information in PMC

References

    1. Unintended Pregnancy and Abortion Worldwide [Internet]. Guttmacher Institute. 2022 Mar [cited 2022 Oct 7]. Available from: https://www.guttmacher.org/fact-sheet/induced-abortion-worldwide.
    1. Sully EA, Biddlecom A, Darroch JE, Riley T, Ashford LS, Lince-Deroche N, et al. Adding it up: investing in sexual and reproductive health 2019 [Internet]. New York: Guttmacher Institute; 2020 Jul [cited 2022 Sep 9]. Available from: https://www.guttmacher.org/report/adding-it-up-investing-in-sexual-repro....
    1. Fu L, Sun Y, Han M, Wang B, Xiao F, Zhou Y, et al. Incidence trends of five common sexually transmitted infections excluding HIV from 1990 to 2019 at the global, regional, and national levels: results from the Global Burden of Disease Study 2019. Front Med (Lausanne) 2022;9:851635. doi: 10.3389/fmed.2022.851635. - DOI - PMC - PubMed
    1. Van Gerwen OT, Muzny CA, Marrazzo JM. Sexually transmitted infections and female reproductive health. Nat Microbiol. 2022;7(8):1116–1126. doi: 10.1038/s41564-022-01177-x. - DOI - PMC - PubMed
    1. Ward H, Rönn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5(4):305–310. doi: 10.1097/COH.0b013e32833a8844. - DOI - PMC - PubMed

Substances